Vulnerability Details : CVE-2015-10032
A vulnerability was found in HealthMateWeb. It has been declared as problematic. Affected by this vulnerability is an unknown functionality of the file createaccount.php. The manipulation of the argument username/password/first_name/last_name/company/phone leads to cross site scripting. The attack can be launched remotely. The patch is named 472776c25b1046ecaf962c46fed7c713c72c28e3. It is recommended to apply a patch to fix this issue. The associated identifier of this vulnerability is VDB-217663.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2015-10032
- cpe:2.3:a:healthmateweb_project:healthmateweb:*:*:*:*:*:android:*:*
Exploit prediction scoring system (EPSS) score for CVE-2015-10032
0.13%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 49 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2015-10032
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
4.0
|
MEDIUM | AV:N/AC:L/Au:S/C:N/I:P/A:N |
8.0
|
2.9
|
VulDB | |
3.5
|
LOW | CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N |
2.1
|
1.4
|
VulDB | |
3.5
|
LOW | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N |
2.1
|
1.4
|
VulDB | 2024-02-29 |
6.1
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
2.8
|
2.7
|
NIST |
CWE ids for CVE-2015-10032
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by:
- cna@vuldb.com (Secondary)
- nvd@nist.gov (Primary)
References for CVE-2015-10032
-
https://vuldb.com/?id.217663
Third Party Advisory;VDB Entry
-
https://vuldb.com/?ctiid.217663
Third Party Advisory;VDB Entry
-
https://github.com/StevenElberger/HealthMateWeb/commit/472776c25b1046ecaf962c46fed7c713c72c28e3
Add XSS prevention to createaccount.php, clean up some code · StevenElberger/HealthMateWeb@472776c · GitHubPatch;Third Party Advisory
Jump to